Tarbox Family Office, Inc. Lantheus Holdings, Inc. Transaction History

Tarbox Family Office, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 06, 2022	SELL	$22.54 - $30.44 $22,540 - $30,440	-1,000 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$24.23 - $28.59 $24,230 - $28,590	-1,000 Reduced 50.0%	1,000 $26,000
Q2 2021 Jul 16, 2021	BUY	$19.51 - $27.64 $39,020 - $55,280	2,000 New	2,000 $55,000
Q3 2020 Oct 22, 2020	SELL	$11.98 - $16.34 $958 - $1,307	-80 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$10.34 - $15.51 $827 - $1,240	80 New	80 $1,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.1B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.